We are a professional manufacturer and supplier focused on the R&D, production and global supply of high-quality antibacterial and antiprotozoal active pharmaceutical ingredients (APIs). We are committed to providing pharmaceutical partners worldwide with highly pure, stable and reliable Metronidazole. As a classic and widely used nitroimidazole derivative, it exhibits excellent activity against anaerobic bacteria and protozoa, making it an essential agent in anti-infective therapy.

?

Metronidazole exerts its antimicrobial effect by entering microbial cells and being reduced to active metabolites that damage DNA structure and inhibit nucleic acid synthesis. It shows strong activity against a broad range of anaerobic bacteria, as well as protozoa such as Trichomonas vaginalis, Giardia lamblia and Entamoeba histolytica. Its good oral absorption, tissue penetration and low toxicity support its long?standing clinical application.

?

Clinically, Metronidazole is widely used for the treatment of anaerobic infections including intra?abdominal, gynecological, respiratory, skin and soft tissue, and septic infections. It is also a first?line drug for the treatment of trichomoniasis, giardiasis, intestinal and hepatic amebiasis, and is commonly used in the eradication of Helicobacter pylori.

?

To ensure the highest quality standards, our Metronidazole is manufactured under strict GMP guidelines. We implement full?process quality control from raw material sourcing, synthesis and purification to final analysis using advanced detection methods such as HPLC, guaranteeing high purity, low impurities and excellent batch?to?batch consistency. Our product is supported by complete international certification documents including DMF, COPP and GMP, fully complying with regulatory requirements of major global markets.

?

We are committed to providing stable supply, comprehensive technical support and complete registration dossiers for our global partners. With reliable quality, professional service and strong production capacity, we aim to build long?term cooperative relationships and jointly promote the development of safe and effective anti?infective pharmaceuticals.